Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds

Glioblastoma (GBM) is the most common aggressive malignant tumor in brain neuroepithelial tumors and remains incurable. A variety of treatment options are currently being explored to improve patient survival, including small molecule inhibitors, viral therapies, cancer vaccines, and monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Qiu, Weimin, Sun, Tianyu, Wang, Lei, Du, Chenxi, Hu, Yanyu, Liu, Wenyuan, Feng, Feng, Chen, Yao, Sun, Haopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279645/
https://www.ncbi.nlm.nih.gov/pubmed/35847506
http://dx.doi.org/10.1016/j.apsb.2021.12.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279645/
https://www.ncbi.nlm.nih.gov/pubmed/35847506
http://dx.doi.org/10.1016/j.apsb.2021.12.019

Ejemplares similares